Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ofatumumab Extension in RA
NCT00655824Phase 2Terminated
- Sponsor
- GSK
- Start
- Jan 2008
- Primary completion
- May 2011
- Modality
- Monoclonal Antibodies
- Countries
- 5
01
Overview
A Phase 2 trial of ofatumumab in rheumatoid arthritis (RA), sponsored by GSK. Started Jan 2008; status: terminated.
02
Drugs
ofatumumab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00655824.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00655824.